Development of Sustained-Release Ophthalmic Formulation Based on Tranilast Solid Nanoparticles

Eye drops containing Tranilast (TL), N-(3,4-dimethoxycinnamoyl) anthramilic acid, are used as an anti-allergic conjunctivitis drug in the ophthalmic field. Traditional eye drops are very patient compliant, although the bioavailability (BA) of most eye drops is low since eye drops cannot be instilled...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Misa, Seiriki, Ryotaro, Otake, Hiroko, Nakazawa, Yosuke, Kanai, Kazutaka, Tanino, Tadatoshi, Nagai, Noriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178381/
https://www.ncbi.nlm.nih.gov/pubmed/32260210
http://dx.doi.org/10.3390/ma13071675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178381/
https://www.ncbi.nlm.nih.gov/pubmed/32260210
http://dx.doi.org/10.3390/ma13071675

Ejemplares similares